Mismatch Repair Deficiency Linked to Improved Survival in Resectable Oesophagogastric Cancer

https://www.medscape.com/viewarticle/mismatch-repair-deficiency-linked-improved-survival-2026a1000wp8?src= In an analysis of patients with resectable oesophagogastric adenocarcinoma from two large trials, those with mismatch repair-deficient (MMRd) tumours treated with perioperative chemotherapy had significantly better survival than those with MMR-proficient (MMRp) tumours, and chemotherapy did not erase that advantage.